Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10. (Q44277852)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

2,4-Dimethyl-5-[7-[2-methyl-6-(2,3,8-trihydroxy-3-methyl-1,7,12-trioxo-2,4-dihydrobenzo[a]anthracen-9-yl)oxan-3-yl]oxy-7-oxohepta-1,3,5-trienyl]-1,3-dioxolane-2-carboxylic acid

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

11

Ryuichi Sawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Masayuki Igarashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Takafumi Watanabe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tomohiro Hashida

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maya Umekita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Masaki Hatano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yohei Yanagida

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hirokazu Kino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Naoko Kinoshita

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Kunio Inoue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yoshio Nishimura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ryutaro Utsumi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Akio Nomoto

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 February 2020

https://www.nature.com/articles/ja201333.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2013.33?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

459-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2013.33?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

cites work

Biological insights from structures of two-component proteins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Two-component signal transduction as potential drug targets in pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

The biology and future prospects of antivirulence therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Two-component signal transduction in Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Protein kinases as antibacterial targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Histidine kinases as targets for new antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Targeting two-component signal transduction: a novel drug discovery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

21 January 2018

A short history of SHELX

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

Dioxamycin, a new benz[a]anthraquinone antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

7 January 2021

Studies on a new antibiotic pigment, aquayamycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

7 January 2021

Isolation, characterization, and structure of rabelomycin, a new antibiotic

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

7 January 2021

Sakyomicins A, B, C and D: new quinone-type antibiotics produced by a strain of Nocardia. Taxonomy, production, isolation and biological properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2013.33

7 January 2021

Identifiers

DOI

10.1038/JA.2013.33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23632918%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference